95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-199.50%
Negative revenue growth while NEM stands at 38.25%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-199.50%
Negative gross profit growth while NEM is at 77.36%. Joel Greenblatt would examine cost competitiveness or demand decline.
-251.32%
Negative EBIT growth while NEM is at 45.37%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-251.32%
Negative operating income growth while NEM is at 45.37%. Joel Greenblatt would press for urgent turnaround measures.
-511.39%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-511.27%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-511.27%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1856.19%
OCF growth above 1.5x NEM's 112.32%. David Dodd would confirm a clear edge in underlying cash generation.
1856.19%
FCF growth above 1.5x NEM's 702.24%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-278.69%
Negative 10Y revenue/share CAGR while NEM stands at 50.57%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-278.69%
Negative 5Y CAGR while NEM stands at 29.29%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-36363820.17%
Negative 3Y CAGR while NEM stands at 15.47%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.92%
Negative 3Y OCF/share CAGR while NEM stands at 666.93%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-31219.63%
Negative 3Y CAGR while NEM is 201.39%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Firm’s AR is declining while NEM shows 136.24%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-100.00%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-41.90%
Negative asset growth while NEM invests at 15.95%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-33.48%
We have a declining book value while NEM shows 2.08%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-100.00%
We’re deleveraging while NEM stands at 76.97%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-190.08%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.